查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1476368

2030 年经肠营养市场预测：按产品、阶段、最终用户和地区分類的全球分析

Enteral Feeding Formulas Market Forecasts to 2030 - Global Analysis By Product, Stage, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球经肠营养市场规模为 58 亿美元，预计在预测期内将以 11.7% 的复合年增长率增长，到 2030 年达到 126 亿美元。

经肠营养市场包括各种特殊液体营养产品，旨在满足口服摄取困难人口的营养需求。这些配方奶粉绕过口腔，透过饲管直接进入胃肠道。经肠营养市场迎合各种患者的需求，包括老年人、严重患者和残障人士。

根据 IDF 2021 的数据，大约有 5.37 亿成年人患有糖尿病，预计到 2030 年这一数字将增至 6.43 亿，到 2045 年将增至 7.83 亿。

慢性病增加

癌症、胃肠道疾病和神经病变等疾病的全球流行正在增加对经肠营养解决方案的需求。这些疾病常导致患者吞嚥消化固态食物困难，需要经肠营养等替代餵食方法。经肠营养提供了一种方便有效的方法，绕过口服途径，将必需的营养素直接输送到胃肠道。

特殊处方价格昂贵

经肠营养专为满足患有特定医疗状况或饮食状况（例如胃肠道疾病、代谢紊乱或术后恢復）的人群的营养需求而量身定制。然而，这些专用配方的价格高昂，超出了许多患者的经济承受能力，从而减少了需求并阻碍了市场扩张。然而，医疗机构和保险公司经常面临预算限制，进一步限制了他们为有需要的患者购买这些昂贵製剂的能力。

营养不良流行病

营养不良是世界普遍存在的问题，由于慢性病、人口老化和饮食摄取不足等因素，影响着各个年龄层的个人。经肠营养提供了一个重要的解决方案，可以直接向无法有效摄取食物或吸收营养的人提供所需的营养。随着人们对营养在医疗保健中重要性的认识不断增强，加上医疗技术的进步和医疗成本的不断上升，对经肠营养的需求不断增加。

患者缺乏意识且经肠营养报销不足

许多需要经肠营养支持的患者可能不完全理解适当营养补充的重要性或针对其需求量身定制专门配方的可用性。这种认知的缺乏导致经肠营养产品的利用不足，阻碍了市场的成长。经肠营养的充足报销是经肠营养市场的主要障碍。经肠营养是口服餵食困难患者医疗照护的重要组成部分，并且高度依赖医疗保健系统和保险提供者的报销。

COVID-19 的影响：

全球供应链中断导致製造这些配方所需的原材料和成分短缺，从而导致生产延误和供应链限制。封锁措施和对非必要医疗程序的限制导致住院和择期手术减少，从而导致需要肠道餵食的患者减少。然而，随着医疗保健系统已经适应了这一流行病并开始处理积压的延期手术，由于未来病毒浪潮的不确定性以及对医疗保健服务的潜在干扰可能会持续或可能逐渐增加，对经肠营养的需求有所增加。

预计在预测期内，针对特定疾病的牛奶产业将是最大的。

透过满足患有各种疾病的患者的独特营养需求，预计特定疾病特异性奶粉在预测期内将增长最快。这些特异性疾病的配方是为了满足糖尿病、癌症、胃肠道疾病和肾衰竭等疾病患者的独特饮食需求而配製的。透过提供量身订製的营养，这些配方可以优化患者的治疗效果，促进更快的康復，并改善整体医疗保健。

预计长期照护设施领域在预测期内复合年增长率最高

预计长期照护设施产业在预测期内将出现最高的复合年增长率。由于 LTCF 为慢性病患者、残疾人士或口服餵食有困难的患者提供服务，因此这些设施内对经肠营养的需求始终很高。这些设施通常收容患有吞嚥困难、失智症和中风等疾病的老年人，他们需要个人化的营养支持。因此，LTCF 已成为推动经肠营养开发和创新的重要细分市场，製造商投资研发以满足该细分市场独特的营养需求和偏好。

比最大的地区

在估计期间，亚太地区占据了最大的市场份额。由于早产儿的消化器官系统不发达，他们通常需要专门的营养支持，而经肠营养奶粉是他们护理的重要组成部分。随着早产儿数量的增加，该地区对针对早产儿独特需求量身定制的高品质、营养丰富的经肠营养的需求不断增长。需求的激增导致医疗保健提供者和设施大量采购经肠营养，从而推动了区域成长。

复合年增长率最高的地区：

预计欧洲地区在预测期内将保持盈利成长。欧洲食品安全局 (EFSA) 和欧洲药品管理局 (EMA) 等严格的法规结构为经肠营养的製造、标籤和分销制定了标准。这些法规要求进行彻底的测试、成分透明度以及遵守特定的营养指南。此外，欧洲政府对经肠营养实施的报销政策透过促进有需要的患者获得产品进一步刺激市场成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球经肠营养市场：副产品

  • 标准型
  • 按病种开药
    • 阿兹海默症
    • 癌症治疗
    • 吸收不良
    • 糖尿病
    • 罕见疾病
    • 慢性肾臟病
  • 其他产品

第六章全球经肠营养市场：依阶段

  • 儿童
  • 成人

第七章全球经肠营养市场：依最终用户分类

  • 医院
  • 居家照护
  • 长期照护设施
  • 其他最终用户

第八章全球经肠营养市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • Danone SA
  • Primus Pharmaceuticals, Inc
  • Fresenius Kabi AG
  • Meiji Holdings. Co., Ltd
  • Abbott
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Nestle
  • B. Braun Melsungen AG
  • Nutritional Medicinals, LLC
  • Medtrition Inc
  • DermaRite Industries, LLC
Product Code: SMRC25914

According to Stratistics MRC, the Global Enteral Feeding Formulas Market is accounted for $5.8 billion in 2023 and is expected to reach $12.6 billion by 2030 growing at a CAGR of 11.7% during the forecast period. The enteral feeding formulas market encompasses a range of specialized liquid nutrition products designed to meet the nutritional needs of individuals who are unable to consume food orally. These formulas are administered directly into the gastrointestinal tract through feeding tubes, bypassing the oral cavity. The enteral feeding formulas market serves a diverse range of patients, including the elderly, critically ill, and individuals with disabilities.

According to the IDF 2021, approximately 537 million adults are living with diabetes, and the number of people adults living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

As conditions such as cancer, gastrointestinal disorders, and neurological disorders become more prevalent globally, the demand for enteral nutrition solutions rises. These conditions often result in patients experiencing difficulty in swallowing or digesting solid food, necessitating alternative feeding methods like enteral nutrition. Enteral feeding formulas offer a convenient and effective way to deliver essential nutrients directly into the gastrointestinal tract, bypassing the oral route.

Restraint:

High cost of specialized formulas

These formulas are tailored to meet the nutritional needs of individuals with specific medical conditions or dietary requirements, such as those with gastrointestinal disorders, metabolic diseases, or recovering from surgery. However, the exorbitant prices of these specialized formulas make them financially inaccessible to many patients, leading to decreased demand and hindering market expansion. However, healthcare facilities and insurers often face budget constraints, further limiting their ability to procure these costly formulas for patients in need.

Opportunity:

Growing prevalence of malnutrition

Malnutrition is a widespread issue globally, affecting individuals across various age groups due to factors such as chronic illnesses, aging populations, and inadequate dietary intake. Enteral feeding formulas provide a crucial solution for delivering essential nutrients directly to individuals who are unable to consume food orally or absorb nutrients effectively. With the rising awareness about the importance of nutrition in healthcare, coupled with advancements in medical technology and increasing healthcare expenditure, the demand for enteral feeding formulas is on the rise.

Threat:

Lack of patient awareness and insufficient reimbursements for enteral nutrition

Many individuals requiring enteral nutrition support may not fully understand the importance of proper nutrition or the availability of specialized formulas tailored to their needs. This lack of awareness leads to underutilization of enteral feeding products, thereby hindering market growth. Insufficient reimbursements for enteral nutrition are significantly hindering the Enteral Feeding Formulas Market. Enteral nutrition, a critical component of medical care for individuals unable to consume food orally, relies heavily on reimbursements from healthcare systems or insurance providers.

Covid-19 Impact:

Disruptions in the global supply chain led to shortages of raw materials and ingredients essential for manufacturing these formulas, resulting in production delays and supply chain constraints. Lockdown measures and restrictions on non-essential medical procedures reduced hospital admissions and elective surgeries, leading to a decline in the number of patients requiring enteral nutrition support. However, as healthcare systems adapted to the pandemic and began to address the backlog of postponed procedures, the demand for enteral feeding formulas may have gradually rebounded, albeit with ongoing uncertainties regarding future waves of the virus and potential disruptions to healthcare services.

The Disease-specific Formula segment is expected to be the largest during the forecast period

Disease-specific Formula segment is expected to be the largest during the forecast period by catering to the specific nutritional needs of patients with various medical conditions. These specialized formulas are formulated to address the unique dietary requirements of individuals suffering from diseases such as diabetes, cancer, gastrointestinal disorders, and renal failure, among others. By providing tailored nutrition, these formulas optimize patient outcomes, promote faster recovery, and improve overall health management.

The Long Term Care Facilities segment is expected to have the highest CAGR during the forecast period

Long Term Care Facilities segment is expected to have the highest CAGR during the forecast period. As LTCFs cater to individuals with chronic illnesses, disabilities, or those who are unable to consume food orally, the demand for enteral feeding formulas within these facilities is consistently high. These facilities often house elderly individuals with conditions such as dysphagia, dementia, or stroke, who require tailored nutritional support. Consequently, LTCFs represent a crucial market segment driving the development and innovation of enteral feeding formulas, prompting manufacturers to invest in research and development to meet the specific nutritional needs and preferences of this demographic.

Region with largest share:

Asia Pacific region commanded the largest share of the market over the extrapolated period. Preterm infants often require specialized nutritional support due to their underdeveloped gastrointestinal systems, making enteral feeding formulas a vital component of their care. With an increasing number of preterm births, there's a growing demand for high-quality, nutrient-rich enteral feeding formulas tailored to the unique needs of premature infants in the region. This surge in demand has prompted healthcare providers and facilities to procure a greater volume of enteral feeding formulas, thereby driving regional growth.

Region with highest CAGR:

Europe region is poised to hold profitable growth during the forecast period. Stringent regulatory frameworks such as the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) set standards for the production, labeling, and distribution of enteral feeding formulas. These regulations mandate thorough testing, ingredient transparency, and adherence to specific nutritional guidelines. Moreover, reimbursement policies implemented by European governments for enteral nutrition products further stimulate market growth by facilitating access for patients in need.

Key players in the market

Some of the key players in Enteral Feeding Formulas market include Danone S.A, Primus Pharmaceuticals, Inc, Fresenius Kabi AG, Meiji Holdings. Co., Ltd, Abbott, Hormel Foods Corporation, Mead Johnson & Company, LLC, Nestle, B. Braun Melsungen AG, Nutritional Medicinals, LLC, Medtrition Inc and DermaRite Industries, LLC.

Key Developments:

In September 2023, Abbott announced the plan to boost manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.

In February 2023, Nestle and EraCal Therapeutics initiated a research collaboration to identify novel nutraceuticals for controlling food intake

In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste.

In September 2022, Kate Farms raised USD 75 million in a Series C funding round led by life-science investor Novo Holdings. With this, Kate Farms will be able to increase its efforts in developing plant-based clinical nutrition research, product innovation, and development into more channels.

Products Covered:

  • Standard Formula
  • Disease-specific Formula
  • Other Products

Stages Covered:

  • Pediatric
  • Adult

End Users Covered:

  • Hospitals
  • Home Care
  • Long Term Care Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Enteral Feeding Formulas Market, By Product

  • 5.1 Introduction
  • 5.2 Standard Formula
  • 5.3 Disease-specific Formula
    • 5.3.1 Alzheimer's Disease
    • 5.3.2 Cancer Care
    • 5.3.3 Malabsorption
    • 5.3.4 Diabetes
    • 5.3.5 Orphan Diseases
    • 5.3.6 Chronic Kidney Diseases
  • 5.4 Other Products

6 Global Enteral Feeding Formulas Market, By Stage

  • 6.1 Introduction
  • 6.2 Pediatric
  • 6.3 Adult

7 Global Enteral Feeding Formulas Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Home Care
  • 7.4 Long Term Care Facilities
  • 7.5 Other End Users

8 Global Enteral Feeding Formulas Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Danone S.A
  • 10.2 Primus Pharmaceuticals, Inc
  • 10.3 Fresenius Kabi AG
  • 10.4 Meiji Holdings. Co., Ltd
  • 10.5 Abbott
  • 10.6 Hormel Foods Corporation
  • 10.7 Mead Johnson & Company, LLC
  • 10.8 Nestle
  • 10.9 B. Braun Melsungen AG
  • 10.10 Nutritional Medicinals, LLC
  • 10.11 Medtrition Inc
  • 10.12 DermaRite Industries, LLC

List of Tables

  • Table 1 Global Enteral Feeding Formulas Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 4 Global Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 5 Global Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 6 Global Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 7 Global Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 8 Global Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 9 Global Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 10 Global Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 11 Global Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 13 Global Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 14 Global Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 15 Global Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 16 Global Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 17 Global Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 18 Global Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 19 Global Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 20 North America Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 22 North America Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 23 North America Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 24 North America Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 25 North America Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 26 North America Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 27 North America Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 28 North America Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 29 North America Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 30 North America Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 31 North America Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 32 North America Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 33 North America Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 34 North America Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 North America Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 North America Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 37 North America Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 38 North America Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 39 Europe Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 41 Europe Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 42 Europe Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 43 Europe Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 44 Europe Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 45 Europe Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 46 Europe Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 47 Europe Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 48 Europe Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 49 Europe Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 50 Europe Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 51 Europe Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 52 Europe Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 53 Europe Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 54 Europe Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 55 Europe Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 56 Europe Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 57 Europe Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 58 Asia Pacific Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 60 Asia Pacific Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 61 Asia Pacific Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 62 Asia Pacific Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 63 Asia Pacific Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 64 Asia Pacific Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 65 Asia Pacific Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 66 Asia Pacific Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 67 Asia Pacific Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 68 Asia Pacific Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 69 Asia Pacific Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 70 Asia Pacific Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 71 Asia Pacific Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 72 Asia Pacific Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 73 Asia Pacific Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 74 Asia Pacific Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 75 Asia Pacific Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 76 Asia Pacific Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 77 South America Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 79 South America Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 80 South America Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 81 South America Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 82 South America Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 83 South America Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 84 South America Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 85 South America Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 86 South America Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 87 South America Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 88 South America Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 89 South America Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 90 South America Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 91 South America Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 92 South America Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 93 South America Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 94 South America Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 95 South America Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 96 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
  • Table 98 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
  • Table 99 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
  • Table 100 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 101 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
  • Table 102 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
  • Table 103 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 104 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
  • Table 105 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
  • Table 106 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 107 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
  • Table 108 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 109 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
  • Table 110 Middle East & Africa Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 112 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 113 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
  • Table 114 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)